Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > WTF?

<< Previous

Bullboard Posts

Next >>

Comment by greaterfoolFredon Apr 27, 2021 2:12pm

151 Views

Post# 33075530

RE:RE:RE:RE:RE:RE:WTF?

I think the biggest positive in the Newsletter is the tox studies moving forward for Rutherin, leading to a first indication for Rutherin/radiation treatment. This will be huge. After one indication is approved, many more will follow very quickly. We just have to get GLP tox studies done as fast as possible.
Good luck all.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec